Blackstone Strategic Partners specializes in acquiring secondary interests in various asset classes, providing liquidity solutions and co-investment opportunities globally. With $69 billion in assets under management, the company is a trusted counterparty known for its diversified approach, detailed analysis, and significant capital appreciation strategies in real estate and other sectors. Founded on the principle of mutual benefit for all parties involved, it leverages an extensive network and industry knowledge to execute transactions effectively.
- Specialty Chemicals
- Pharmaceuticals
- Life Sciences
- Microelectronics
- Manufacturing
Recent Transactions involving Blackstone Strategic Partners
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Wind Point Simultaneously Exits And Reinvests In Ascensus Through Blackstone Strategic Partners-Led SPV |
Ascensus Specialties |
New Mountain CapitalBlackstone Strategic PartnersWind Point Partners |
Specialty Chemicals |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →